Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Gelber

Showing results (71-80 of 395) with videos related to

Pageof 40
Sort By:
European Journal of Cancer (Oxford, England : 1990)|May 22, 2007
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VIAnn Partridge, Shari Gelber, Richard D Gelber, et al.
Surgery|May 1, 1979
Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones"C G Moertel, P Engstrom, P T Lavin, et al.
Statistics in Medicine|July 22, 1998
Quality adjusted survival analysis with repeated quality of life measuresP P Glasziou, B F Cole, R D Gelber, et al.
AJNR. American Journal of Neuroradiology|February 1, 1994
Posttraumatic cutaneous meningioma of the faceG A Walters, R L Ragland, J R Knorr, et al.
Clinical Trials (London, England)|October 24, 2015
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPPAnn A Lazar, Marco Bonetti, Bernard F Cole, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Chemotherapy benefit for 'ER-positive' breast cancer and contamination of nonluminal subtypes—waiting for TAILORx and RxPONDERZ Sun, A Prat, M C U Cheang, et al.
Breast Cancer Research : BCR|June 4, 2011
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancerMeredith M Regan, Karen N Price, Anita Giobbie-Hurder, et al.
Neuroradiology|January 1, 1992
Cerebellar T-cell lymphoma: an unusual primary intracranial neoplasmJ R Knorr, R L Ragland, B B Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemiaD P Waber, N J Tarbell, C M Kahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group studyB F Cole, R D Gelber, J M Kirkwood, et al.
Pageof 40

Showing results (71-80 of 395) with videos related to

Sort By:
Pageof 40
European Journal of Cancer (Oxford, England : 1990)|May 22, 2007
Age of menopause among women who remain premenopausal following treatment for early breast cancer: long-term results from International Breast Cancer Study Group Trials V and VIAnn Partridge, Shari Gelber, Richard D Gelber, et al.
Surgery|May 1, 1979
Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones"C G Moertel, P Engstrom, P T Lavin, et al.
Statistics in Medicine|July 22, 1998
Quality adjusted survival analysis with repeated quality of life measuresP P Glasziou, B F Cole, R D Gelber, et al.
AJNR. American Journal of Neuroradiology|February 1, 1994
Posttraumatic cutaneous meningioma of the faceG A Walters, R L Ragland, J R Knorr, et al.
Clinical Trials (London, England)|October 24, 2015
Identifying treatment effect heterogeneity in clinical trials using subpopulations of events: STEPPAnn A Lazar, Marco Bonetti, Bernard F Cole, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 31, 2014
Chemotherapy benefit for 'ER-positive' breast cancer and contamination of nonluminal subtypes—waiting for TAILORx and RxPONDERZ Sun, A Prat, M C U Cheang, et al.
Breast Cancer Research : BCR|June 4, 2011
Interpreting Breast International Group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancerMeredith M Regan, Karen N Price, Anita Giobbie-Hurder, et al.
Neuroradiology|January 1, 1992
Cerebellar T-cell lymphoma: an unusual primary intracranial neoplasmJ R Knorr, R L Ragland, B B Stone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1992
The relationship of sex and treatment modality to neuropsychologic outcome in childhood acute lymphoblastic leukemiaD P Waber, N J Tarbell, C M Kahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Quality-of-life-adjusted survival analysis of interferon alfa-2b adjuvant treatment of high-risk resected cutaneous melanoma: an Eastern Cooperative Oncology Group studyB F Cole, R D Gelber, J M Kirkwood, et al.
Pageof 40